The reduced metabolites of progesterone (3α-hydroxy-5α-pregnan-20-one or 3α,5α-P) and deoxycorticosterone (3α,21-dihydroxy-5α-pregnan-20-one or 5α-THDOC) exhibit a γ-aminobutyric acid (GABA) agonist pharmacological profile and bind with high affinity to a unique steroid recognition site on the GABA(A) receptor complex (GRC). In female rats, peak levels of 3α,5α-P occur between proestrus and estrus and at concentrations which appear sufficient to affect GRC-mediated inhibitory events. Therefore, steroid modulation of the binding of [35S]t-butylbicyclophosphorothionate was conducted to examine sensitivity of the GRC during the estrus cycle. The results in unwashed tissue (cortex, cerebellum, hippocampus and striatum) indicated that 3α,5α-P was most potent in estrus. Subsequent studies in washed tissue and in washed tissue plus 3 μM (+)bicuculline indicated that 3α,5α-P was more potent in diestrus 1 than in estrus. Brain regional differences in potency of 3α,5α-P were also observed. Overall, the results in washed tissue suggest that an inherent change in the sensitivity of the GRC occurs during the estrus cycle, whereas the results in unwashed tissue may be influenced by the presence of endogenous GRC-active neurosteroids and GABA. The change in sensitivity of the GRC during the estrus cycle may occur to help maintain homeostatic regulation of brain excitability.
|Original language||English (US)|
|Number of pages||6|
|Journal||Journal of Pharmacology and Experimental Therapeutics|
|State||Published - Jan 1 1993|
ASJC Scopus subject areas
- Molecular Medicine